[go: up one dir, main page]

EA200100568A1 - Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы - Google Patents

Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы

Info

Publication number
EA200100568A1
EA200100568A1 EA200100568A EA200100568A EA200100568A1 EA 200100568 A1 EA200100568 A1 EA 200100568A1 EA 200100568 A EA200100568 A EA 200100568A EA 200100568 A EA200100568 A EA 200100568A EA 200100568 A1 EA200100568 A1 EA 200100568A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxypropylmethil
capsules
cellulose
pharmaceutical compositions
compositions
Prior art date
Application number
EA200100568A
Other languages
English (en)
Inventor
Паола Чивароли
Лорена Муджетти
Алессандро Мартини
Original Assignee
Фармация Энд Апджон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон С.П.А. filed Critical Фармация Энд Апджон С.П.А.
Publication of EA200100568A1 publication Critical patent/EA200100568A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Пероральная фармацевтическая композиция, которая содержит, в капсуле из гидроксипропилметилцеллюлозы аналог камптотецина, диспергированный или солюбилизированный в полутвердом матриксе. Эти композиции применимы для лечения неопластических заболеваний.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100568A 1999-08-10 2000-07-11 Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы EA200100568A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918885.6A GB9918885D0 (en) 1999-08-10 1999-08-10 Pharmaceutical formulations in hydroxypropymethycellulose capsules
PCT/EP2000/006590 WO2001010443A1 (en) 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules

Publications (1)

Publication Number Publication Date
EA200100568A1 true EA200100568A1 (ru) 2001-10-22

Family

ID=10858930

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100568A EA200100568A1 (ru) 1999-08-10 2000-07-11 Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы

Country Status (18)

Country Link
US (1) US6569452B1 (ru)
EP (1) EP1126851B1 (ru)
CN (1) CN1245976C (ru)
AR (1) AR025060A1 (ru)
AT (1) ATE262905T1 (ru)
AU (1) AU6158200A (ru)
CA (1) CA2354039C (ru)
CO (1) CO5200854A1 (ru)
CZ (1) CZ293749B6 (ru)
DE (1) DE60009442D1 (ru)
EA (1) EA200100568A1 (ru)
GB (1) GB9918885D0 (ru)
HK (1) HK1040930B (ru)
HU (1) HUP0104476A3 (ru)
IL (2) IL143502A0 (ru)
NO (1) NO319712B1 (ru)
PE (1) PE20010407A1 (ru)
WO (1) WO2001010443A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
CN1316970C (zh) * 2002-11-14 2007-05-23 武汉华中科大纳米药业有限公司 一种羟喜树碱固体分散物及其制剂
JP2005183361A (ja) * 2003-10-03 2005-07-07 Ngk Insulators Ltd 電子放出素子、電子放出装置、ディスプレイ及び光源
US20050208146A1 (en) * 2003-10-30 2005-09-22 Pfizer Inc Novel dosage and administration method for oral camptosar
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
CA2663558C (en) * 2006-09-26 2013-05-28 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
US20140121178A1 (en) * 2011-06-24 2014-05-01 Acenda Pharma Inc. Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
CN103110605A (zh) * 2011-11-17 2013-05-22 天士力制药集团股份有限公司 一种热熔胶囊制剂及其制备方法
CN110946836A (zh) * 2014-01-17 2020-04-03 昂科拉制药有限公司 用于治疗癌症的伊立替康的固体口服剂型
CN105287427B (zh) * 2015-10-20 2017-04-19 沈阳红旗制药有限公司 一种利福平半固体胶囊及其制备方法
KR102066402B1 (ko) * 2017-12-22 2020-01-15 대화제약 주식회사 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US5597829A (en) 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
WO1995029677A1 (en) 1994-04-28 1995-11-09 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin or 7-ethyl camptothecin
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
KR20000029784A (ko) 1996-08-02 2000-05-25 나까도미 히로다카 경구제제용캡슐과경구캡슐제제
AR013261A1 (es) 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina

Also Published As

Publication number Publication date
NO20013205D0 (no) 2001-06-26
AU6158200A (en) 2001-03-05
WO2001010443A1 (en) 2001-02-15
CN1327387A (zh) 2001-12-19
DE60009442D1 (de) 2004-05-06
IL143502A0 (en) 2002-04-21
HUP0104476A2 (hu) 2002-03-28
CA2354039A1 (en) 2001-02-15
CZ20012089A3 (cs) 2001-10-17
CA2354039C (en) 2008-09-23
HK1040930A1 (en) 2002-06-28
NO20013205L (no) 2001-06-26
NO319712B1 (no) 2005-09-05
HK1040930B (zh) 2006-10-27
CN1245976C (zh) 2006-03-22
EP1126851A1 (en) 2001-08-29
ATE262905T1 (de) 2004-04-15
GB9918885D0 (en) 1999-10-13
CO5200854A1 (es) 2002-09-27
HUP0104476A3 (en) 2004-05-28
IL143502A (en) 2006-12-10
EP1126851B1 (en) 2004-03-31
PE20010407A1 (es) 2001-03-28
AR025060A1 (es) 2002-11-06
CZ293749B6 (cs) 2004-07-14
US6569452B1 (en) 2003-05-27

Similar Documents

Publication Publication Date Title
EA200100568A1 (ru) Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы
NO20022058L (no) Farmasöytiske sammensetninger
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
ATE185562T1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EA200200571A1 (ru) Новая композиция и ее применение
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
EA200100872A1 (ru) Композиция валдекоксиба
ATE429210T1 (de) Orale flüssige zusammensetzungen
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
BR0210139A (pt) Composições farmacêuticas
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ES2171933T3 (es) Derivados de androsteno.
ECSP045301A (es) Uso de derivado de indolopirrolocarbazol y otro agente anticancerosos en combinacion
FR2761066B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
ATE254914T1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
AR022589A1 (es) UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER
DK1167354T3 (da) Racemisk huperzin A
BR0010708A (pt) Glicosìdeos androgênicos e atividade androgênica dos mesmos